FDA Inspection 1320108 — Bioplate Inc

Bioplate Inc — FEI 1000518793

The FDA completed an inspection of Bioplate Inc on Jun 1, 2026 in Placentia, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 1, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Compliance: Devices
Location
Placentia, CA (United States)

Citations

IDCFRDescription
23024ISO 13485:2016 Clause 4.1.5Inadequate monitoring and control over outsourced processes
23086ISO 13485:2016 Clause 7.1Planning of product realization not consistent with other QMS processes
23088ISO 13485:2016 Clause 7.1Records of risk management activities in product realization not maintained
23212ISO 13485:2016 Clause 8.2.1Feedback process procedures not documented
23258ISO 13485:2016 Clause 8.5.2Corrective action procedures not documented

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.